Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (237)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
57
2024
2929
4.050
Why?
Hematopoietic Stem Cell Transplantation
9
2024
565
1.140
Why?
Leukemia, Plasma Cell
2
2020
33
0.900
Why?
Antibodies, Bispecific
4
2024
60
0.830
Why?
Immunotherapy, Adoptive
5
2024
156
0.750
Why?
Bone Marrow
10
2022
362
0.710
Why?
Neoplasms, Plasma Cell
3
2024
37
0.670
Why?
Plasma Cells
6
2023
223
0.610
Why?
Chromosome Deletion
2
2023
140
0.600
Why?
Transplantation, Autologous
10
2024
466
0.590
Why?
Humans
66
2024
49974
0.590
Why?
Chromosomes, Human, Pair 17
1
2017
36
0.580
Why?
Gene Expression Profiling
10
2023
1032
0.560
Why?
Tumor Suppressor Protein p53
2
2017
202
0.550
Why?
Clinical Trials as Topic
4
2022
461
0.540
Why?
Gene Expression Regulation, Neoplastic
6
2021
828
0.530
Why?
Neoplasm, Residual
6
2022
165
0.510
Why?
Proteasome Inhibitors
1
2016
104
0.500
Why?
Immunologic Factors
1
2016
114
0.500
Why?
B-Cell Maturation Antigen
6
2024
90
0.490
Why?
Immunotherapy
1
2016
238
0.460
Why?
Stem Cell Transplantation
5
2024
181
0.450
Why?
Translocation, Genetic
5
2021
264
0.450
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2023
103
0.440
Why?
Antibodies, Monoclonal
2
2022
459
0.440
Why?
Mutation
7
2022
1294
0.440
Why?
Aged
21
2024
9310
0.420
Why?
Prognosis
14
2024
1942
0.420
Why?
Neoplasm Proteins
4
2020
322
0.410
Why?
Neutropenia
2
2023
116
0.410
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.390
Why?
Neoplasms
2
2012
1235
0.390
Why?
Lymphocytes
1
2012
152
0.380
Why?
Cancer Vaccines
1
2011
78
0.360
Why?
Evolution, Molecular
2
2021
99
0.360
Why?
Neoplasm Recurrence, Local
7
2024
614
0.360
Why?
Positron-Emission Tomography
4
2022
295
0.360
Why?
Survival Analysis
7
2021
653
0.340
Why?
Diffusion Magnetic Resonance Imaging
3
2019
123
0.340
Why?
Cytokines
1
2012
612
0.330
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
989
0.300
Why?
Hematologic Neoplasms
2
2022
99
0.300
Why?
Atrial Fibrillation
2
2022
180
0.280
Why?
Combined Modality Therapy
4
2024
637
0.280
Why?
Middle Aged
19
2024
12069
0.270
Why?
Female
24
2024
26472
0.260
Why?
Fluorodeoxyglucose F18
4
2021
192
0.240
Why?
Proto-Oncogene Proteins B-raf
3
2020
79
0.240
Why?
Polycomb Repressive Complex 2
2
2021
47
0.240
Why?
Pentaerythritol Tetranitrate
1
2024
6
0.240
Why?
Aged, 80 and over
7
2021
3129
0.230
Why?
Neoplasms, Second Primary
1
2024
78
0.230
Why?
Treatment Outcome
8
2024
5141
0.230
Why?
Male
22
2024
25241
0.220
Why?
Chromosomes, Human, Pair 1
2
2023
93
0.220
Why?
Adult
15
2024
13236
0.210
Why?
Disease Progression
6
2021
825
0.210
Why?
Paraproteinemias
1
2022
72
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
Osteolysis
1
2022
75
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.200
Why?
Lymphoma, B-Cell
1
2022
63
0.200
Why?
Epigenomics
1
2021
67
0.200
Why?
Patient Participation
1
2022
66
0.190
Why?
T-Lymphocytes
4
2024
338
0.190
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Practice Guidelines as Topic
1
2023
449
0.180
Why?
Cell Cycle
1
2021
231
0.180
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
Why?
Risk Factors
8
2021
3613
0.170
Why?
Bone Resorption
1
2022
304
0.170
Why?
Bone Diseases
1
2021
99
0.170
Why?
Chromosomal Instability
1
2019
16
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
Disease-Free Survival
5
2019
454
0.170
Why?
Antigens, CD
1
2020
219
0.170
Why?
Healthcare Disparities
1
2022
257
0.170
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Spleen
1
2019
172
0.160
Why?
Phosphotransferases
1
2018
16
0.160
Why?
Spinal Fractures
1
2018
38
0.160
Why?
Antineoplastic Agents
2
2024
1171
0.150
Why?
Brain Neoplasms
2
2011
287
0.150
Why?
Bacteremia
1
2019
90
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Gene Rearrangement
1
2018
74
0.150
Why?
Hexokinase
1
2017
17
0.150
Why?
Retinoblastoma Binding Proteins
1
2017
10
0.150
Why?
Recurrence
5
2021
652
0.140
Why?
Epigenesis, Genetic
1
2020
374
0.140
Why?
Calcification, Physiologic
1
2017
41
0.140
Why?
Pelvis
1
2017
68
0.140
Why?
Survival Rate
4
2020
894
0.140
Why?
Cell Proliferation
4
2023
1007
0.140
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
105
0.140
Why?
Immunoglobulin Light Chains
1
2017
81
0.140
Why?
Ubiquitin-Protein Ligases
1
2017
92
0.140
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Flow Cytometry
1
2018
476
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.130
Why?
Gene Expression
1
2018
609
0.130
Why?
Retrospective Studies
6
2024
6108
0.120
Why?
Animals
4
2024
13187
0.120
Why?
Cystatin M
2
2024
20
0.110
Why?
Cross-Sectional Studies
3
2023
1557
0.110
Why?
Cardiovascular Diseases
1
2017
440
0.100
Why?
Tumor Microenvironment
2
2023
212
0.100
Why?
Follow-Up Studies
3
2024
2182
0.100
Why?
Astrocytoma
1
2011
20
0.100
Why?
Lymphoma, Non-Hodgkin
1
2011
60
0.100
Why?
Mutation Rate
2
2021
36
0.090
Why?
Disease Models, Animal
1
2016
1455
0.090
Why?
Glioma
1
2011
79
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
259
0.090
Why?
Alleles
2
2021
250
0.090
Why?
Genomics
2
2023
286
0.090
Why?
Remission Induction
2
2021
207
0.090
Why?
Tumor Burden
2
2020
132
0.090
Why?
Vaccination
1
2011
266
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
66
0.080
Why?
Histones
2
2021
312
0.080
Why?
Transcription Factors
2
2023
561
0.080
Why?
DNA Copy Number Variations
2
2021
110
0.080
Why?
Radiopharmaceuticals
2
2021
209
0.080
Why?
Models, Biological
1
2011
727
0.080
Why?
Cell Differentiation
2
2022
651
0.080
Why?
Transcriptome
2
2020
315
0.070
Why?
Kaplan-Meier Estimate
2
2019
466
0.070
Why?
Imaging, Three-Dimensional
2
2017
151
0.070
Why?
Biopsy
2
2018
584
0.060
Why?
Arkansas
2
2021
1977
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Demography
1
2024
93
0.060
Why?
Myeloid Progenitor Cells
1
2023
18
0.060
Why?
X-Ray Microtomography
1
2024
77
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
Why?
Antibodies
1
2024
154
0.060
Why?
Mice
2
2024
5739
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Signal Transduction
2
2021
1618
0.050
Why?
Patients
1
2022
49
0.050
Why?
Geography
1
2022
61
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Patient Selection
1
2023
253
0.050
Why?
United States Food and Drug Administration
1
2022
93
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
235
0.050
Why?
Bone Marrow Transplantation
1
2022
116
0.050
Why?
Dexamethasone
1
2024
430
0.050
Why?
Chromosome Aberrations
1
2023
297
0.050
Why?
Syndecan-1
1
2021
72
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Clone Cells
1
2021
74
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.050
Why?
Chromatin
1
2021
151
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
225
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Aneuploidy
1
2020
16
0.050
Why?
Pyrimidines
1
2022
192
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.050
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.050
Why?
Histone Code
1
2020
32
0.050
Why?
Cyclin D1
1
2020
56
0.050
Why?
ras Proteins
1
2020
64
0.050
Why?
Genome, Human
1
2021
111
0.050
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.050
Why?
Protein Kinase Inhibitors
1
2022
204
0.040
Why?
DNA, Neoplasm
1
2020
147
0.040
Why?
Health Status Disparities
1
2022
195
0.040
Why?
DNA Mutational Analysis
1
2020
175
0.040
Why?
Genetic Variation
1
2020
213
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
169
0.040
Why?
Cell Line, Tumor
1
2023
1403
0.040
Why?
Osteoclasts
1
2022
425
0.040
Why?
Multivariate Analysis
1
2021
577
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
26
0.040
Why?
Computational Biology
1
2020
214
0.040
Why?
Pseudomonas Infections
1
2019
48
0.040
Why?
Syndrome
1
2019
237
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
427
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Promoter Regions, Genetic
1
2020
475
0.040
Why?
Oncogene Proteins, Fusion
1
2018
58
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
Why?
Protein-Tyrosine Kinases
1
2018
95
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
Retinoblastoma Protein
1
2017
19
0.040
Why?
False Positive Reactions
1
2017
63
0.040
Why?
STAT3 Transcription Factor
1
2017
81
0.040
Why?
Fibroblast Growth Factors
1
2017
47
0.040
Why?
Bone and Bones
1
2021
469
0.040
Why?
Glomerular Filtration Rate
1
2017
111
0.040
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.040
Why?
Amino Acid Sequence
1
2018
585
0.040
Why?
Alkaline Phosphatase
1
2017
94
0.040
Why?
Sequence Analysis, DNA
1
2017
237
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
NF-kappa B
1
2018
314
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
DNA Methylation
1
2020
548
0.030
Why?
Models, Genetic
1
2016
170
0.030
Why?
Genomic Instability
1
2016
92
0.030
Why?
Staphylococcal Infections
1
2019
268
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Logistic Models
1
2018
888
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
141
0.030
Why?
Melphalan
1
2016
174
0.030
Why?
Heart
1
2017
326
0.030
Why?
Kidney Diseases
1
2017
214
0.030
Why?
Algorithms
1
2018
615
0.030
Why?
Echocardiography
1
2017
378
0.030
Why?
Time Factors
1
2021
2903
0.030
Why?
Myocardium
1
2017
436
0.030
Why?
Disease Management
1
2015
174
0.030
Why?
Longitudinal Studies
1
2016
688
0.030
Why?
Thalidomide
1
2016
377
0.030
Why?
Risk Assessment
1
2018
1259
0.030
Why?
Dose-Response Relationship, Drug
1
2016
1376
0.030
Why?
Ifosfamide
1
2011
9
0.020
Why?
Dacarbazine
1
2011
9
0.020
Why?
Tomography, X-Ray Computed
1
2017
1159
0.020
Why?
Carboplatin
1
2011
53
0.020
Why?
Etoposide
1
2011
72
0.020
Why?
United States
1
2022
4860
0.020
Why?
Treatment Failure
1
2011
114
0.020
Why?
Fatal Outcome
1
2011
195
0.020
Why?
Drug Administration Schedule
1
2011
376
0.020
Why?
Magnetic Resonance Imaging
1
2017
1537
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description